KembaliKembaliOperating expenses (excl. COGS) dari Anebulo Pharmaceuticals, Inc..
Data tahunan
−12,00 M
−9,00 M
−6,00 M
−3,00 M
0,00
Periode
Nilai
Perubahan
% Perubahan
TTM
−8,18 M
+131,55 K
+1,58%
2024
−8,31 M
+3,47 M
+29,49%
2023
−11,78 M
−4,95 M
−72,50%
2022
−6,83 M
−3,22 M
−89,03%
2021
−3,61 M
−3,44 M
−1,98 K%
Data per kuartal
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−4,00 M
−3,00 M
−2,00 M
−1,00 M
0,00
Periode
Nilai
Perubahan
% Perubahan
Q1 '25
−2,41 M
−1,07 M
−79,96%
Q4 '24
−1,34 M
+323,88 K
+19,46%
Q3 '24
−1,66 M
+1,10 M
+39,71%
Q2 '24
−2,76 M
−216,78 K
−8,52%
Q1 '24
−2,54 M
−49,29 K
−1,98%
Q4 '23
−2,49 M
+369,65 K
+12,91%
Q3 '23
−2,86 M
+949,08 K
+24,89%
Q2 '23
−3,81 M
−1,20 M
−45,98%